Cargando…
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma
SIMPLE SUMMARY: Neuroblastomas mostly show poor response to the Cisplatin therapy. Amino acids serve as building blocks for proteins, which are acquired either through diet or protein breakdown. Our study reveals high amino acid pools and dependence of Cisplatin-tolerant neuroblastomas cells on amin...
Autores principales: | Gunda, Venugopal, Pathania, Anup S., Chava, Srinivas, Prathipati, Philip, Chaturvedi, Nagendra K., Coulter, Don W., Pandey, Manoj K., Durden, Donald L., Challagundla, Kishore B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563727/ https://www.ncbi.nlm.nih.gov/pubmed/32927667 http://dx.doi.org/10.3390/cancers12092576 |
Ejemplares similares
-
miR-15a and miR-15b modulate natural killer and CD8(+)T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
por: Pathania, Anup S., et al.
Publicado: (2022) -
miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
por: Chava, Srinivas, et al.
Publicado: (2019) -
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
por: Pathania, Anup S., et al.
Publicado: (2021) -
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
por: Kling, Matthew J., et al.
Publicado: (2021) -
The Transcribed-Ultra Conserved Regions: Novel Non-Coding RNA Players in Neuroblastoma Progression
por: Mudgapalli, Nithya, et al.
Publicado: (2019)